Novocure secures FDA approval for add-ons to brain cancer treatment wearable

By Yahoo! Finance | Nov 21, 2024 at 11:59 AM EST

Novocure has obtained FDA clearance for the new head flexible electrode transducer arrays for use with Optune Gio, a wearable for treating glioblastoma. The company plans to transition US users to the improved arrays by mid-2025, aiming to enhance patient comfort and treatment effectiveness.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.